Date/Time
Date(s) - 29/08/2022 - 01/09/2022
All Day
“The IPF Summit is an excellent meeting to learn about the latest advancement in pulmonary fibrosis research, and to network with other scientists who are working towards a common goal of improving the lives of patients with these serious unmet medical needs”
Peter Schafer, Scientific Vice President, Bristol Myers Squibb
“We are excited to meet people on the quest to improve the lives of IPF patients – especially looking for tolerable therapies with a chance to halt the disease”
Bertil Lindmark, Chief Medical Officer, Galecto
“This meeting is an outstanding opportunity to discuss the various challenges with IPF drug development and to collaborate across industry and academics to develop potential pragmatic strategies and solutions for these challenges”
Majd Mouded, Executive Director, Novartis